GOLDMAN SACHS GROUP INC - 31 Dec 2024 SCHEDULE 13G Report for SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0009 per share (SLXN)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SILEXION THERAPEUTICS CORP Ordinary Shares, par value $0.0009 per share
Symbol: SLXN
Shares outstanding: 1,700,636 shares
Disclosed Ownership: 112,242 shares
Ownership: 6.6%
Form type: SCHEDULE 13G
Filing time: 10 Feb 2025, 17:31:22 UTC
Date of event: 31 Dec 2024
Next filing: 13 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	6.6%	112,242	0	112,242	Name: Sam Prashanth	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	6.6%	112,242	0	112,242	Name: Sam Prashanth	Attorney-in-fact